Sarah Loveland Williams
Family Medicine · Charleroi, PANPI 1194499376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 42.4% of the total. Reporting peaked in 2023 at $891 and has fallen 67.0% since, to $294 in 2025.
Across 143 payments — averaging $13.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$812
- AstraZeneca$183
- Axsome Therapeutics, Inc.$182
- Alkermes, Inc.$147
- Teva Pharmaceuticals USA, Inc.$126
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$58
- plus $408 from 13 others
What the payments were for
- Food & beverage$1,915100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $812 |
| AstraZeneca | 5 | $183 |
| Axsome Therapeutics, Inc. | 15 | $182 |
| Alkermes, Inc. | 7 | $147 |
| Teva Pharmaceuticals USA, Inc. | 7 | $126 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $58 |
| Almatica Pharma LLC | 3 | $55 |
| Ironshore Pharmaceuticals Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Neurocrine Biosciences, Inc. | 3 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $32 |
| Exact Sciences | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| Corium, LLC | 2 | $20 |
| Novo Nordisk | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$104
How this compares
$1,915 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 14 | $384 |
| Hydroxyzine Hcl | 17 | $131 |
| Buspirone Hcl | 13 | $89 |
| Escitalopram Oxalate | 11 | $58 |
| Trazodone Hcl | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Charleroi
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.